Your browser doesn't support javascript.
loading
Descriptive epidemiology of 30,223 histopathologically confirmed meningiomas in France: 2006-2015.
Depond, Charles Champeaux; Zouaoui, Sonia; Darlix, Amélie; Rigau, Valérie; Mathieu-Daudé, Hélène; Bauchet, Fabienne; Khettab, Mohamed; Trétarre, Brigitte; Figarella-Branger, Dominique; Taillandier, Luc; Boetto, Julien; Pallud, Johan; Zemmoura, Ilyess; Roche, Pierre-Hugues; Bauchet, Luc.
  • Depond CC; Department of Neurosurgery, Hôpital Privé Clairval - Ramsay Santé, 317 Bd de Redon, 13009, Marseille, France. Charles.ChampeauxDepond@gmail.com.
  • Zouaoui S; Department of Neurosurgery, Gui de Chauliac Hospital, Montpellier University Medical Center, 34295, Montpellier cedex 5, France.
  • Darlix A; Institut de Génomique Fonctionnelle (IGF), University of Montpellier, CNRS, INSERM, 34094, Montpellier, France.
  • Rigau V; Institut de Génomique Fonctionnelle (IGF), University of Montpellier, CNRS, INSERM, 34094, Montpellier, France.
  • Mathieu-Daudé H; Medical Oncology Department, Institut du Cancer de Montpellier, University of Montpellier, 34298, Montpellier, France.
  • Bauchet F; Institut de Génomique Fonctionnelle (IGF), University of Montpellier, CNRS, INSERM, 34094, Montpellier, France.
  • Khettab M; Department of Pathology, Gui-de-Chauliac Hospital, Montpellier University Medical Center, 34295, Montpellier cedex 5, France.
  • Trétarre B; Department of Epidemiology, French Brain Tumour Database, GNOLR, Registre Des Tumeurs de L'Hérault, ICM, 34298, Montpellier cedex 5, France.
  • Figarella-Branger D; Department of Epidemiology, French Brain Tumour Database, GNOLR, Registre Des Tumeurs de L'Hérault, ICM, 34298, Montpellier cedex 5, France.
  • Taillandier L; Institut de Génomique Fonctionnelle (IGF), University of Montpellier, CNRS, INSERM, 34094, Montpellier, France.
  • Boetto J; Medical Oncology Unit, CHU de La Réunion, Université de La Réunion, 97410, Saint Pierre, France.
  • Pallud J; Registre Des Tumeurs de L'Hérault, ICM, 34298, Montpellier cedex 5, France.
  • Zemmoura I; Institut de Neurophysiopathologie, Service d'Anatomie Pathologique Et de Neuropathologie, Aix-Marseille University, APHM, CNRS, INP, CHU Timone, 13005, Marseille, France.
  • Roche PH; Department of Neurology, University Hospital of Nancy, Nancy, France.
  • Bauchet L; Department of Neurosurgery, Gui de Chauliac Hospital, Montpellier University Medical Center, 34295, Montpellier cedex 5, France.
Acta Neurochir (Wien) ; 166(1): 214, 2024 May 14.
Article en En | MEDLINE | ID: mdl-38740641
ABSTRACT
BACKGROUND AND

OBJECTIVES:

Meningioma is one of the most common neoplasm of the central nervous system. To describe the epidemiology of meningioma operated in France and, to assess grading and histopathological variability among the different neurosurgical centres.

METHODS:

We processed the French Brain Tumour Database (FBTDB) to conduct a nationwide population-based study of all histopathologically confirmed meningiomas between 2006 and 2015.

RESULTS:

30,223 meningiomas cases were operated on 28,424 patients, in 61 centres. The average number of meningioma operated per year in France was 3,022 (SD ± 122). Meningioma was 3 times more common in women (74.1% vs. 25.9%). The incidence of meningioma increased with age and, mean age at surgery was 58.5 ± 13.9 years. Grade 1, 2, and 3 meningiomas accounted for 83.9%, 13.91% and, 2.19% respectively. There was a significant variability of meningioma grading by institutions, especially for grade 2 which spanned from 5.1% up to 22.4% (p < 0.001). Moreover, the proportion of grade 2 significantly grew over the study period (p < 0.001). There was also a significant variation in grade 1 subtypes diagnosis among the institutions (p < 0.001). 89.05% of the patients had solely one meningioma surgery, 8.52% two and, 2.43% three or more. The number of surgeries was associated to the grade of malignancy (p < 0.001).

CONCLUSION:

The incidence of meningioma surgery increased with age and, peaked at 58.5 years. They were predominantly benign with meningothelial subtype being the most common. However, there was a significant variation of grade 1 subtypes diagnosis among the centres involved. The proportion of grade 2 meningioma significantly grew over the study time, on contrary to malignant meningioma proportion, which remained rare and, stable over time around 2%. Likewise, there was a significant variability of grade 2 meningioma rate among the institutions.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Meníngeas / Meningioma Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Meníngeas / Meningioma Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2024 Tipo del documento: Article